Brief: Vita 34 Develops Cell Preparations As Source Material For Immune Cell Therapies

FamiCord AG

08/02/2019 07:01

Feb 8 (Reuters) - Vita 34 AG  V3VGn.DE :
    * DGAP-NEWS: VITA 34 DEVELOPS CELL PREPARATIONS AS THE SOURCE MATERIAL FOR IMMUNE CELL
THERAPIES
AND BECOMES CELL BANK
    * CHANGE FROM STEM CELL BANK TO BROADER CELL BANK INITIATED
    * CRYOPRESERVATION OF IMMUNE CELLS FROM PERIPHERAL BLOOD AND UMBILICAL CORD BLOOD FROM 2020
    * SIGNIFICANT EXPANSION OF MARKET POTENTIAL BASED ON EXISTING CUSTOMER BASE
    * EXPENDITURES FOR RESEARCH AND DEVELOPMENT WILL, AS USUAL, BE AROUND THREE PERCENT OF SALES
IN
2019 AND 2020

Source text for Eikon:  ID:nEQ43tP8sa 
Further company coverage:  V3VGn.DE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))